Pin your most used calculators here by clicking the star in the dropdown.
AFIP GIST Risk (Miettinen)
Clinical Context & Background
The AFIP (Miettinen) criteria improve upon the NIH criteria by incorporating tumor location (Stomach, Duodenum, Jejunum/Ileum, Rectum), recognizing that gastric GISTs generally have a better prognosis than intestinal GISTs of similar size/grade.
Formula Logic
Risk of progression % based on Size, Mitoses, and Site.Reference Data
| Risk Group | Risk of Progression |
|---|---|
| None | 0% |
| Very Low | 1 - 10% |
| Moderate | 10 - 30% |
| High | > 30% |
Related Tools
Evidence-based oncology decision support. Verify with clinical guidelines.